{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:27:30Z","timestamp":1793597250666,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018286","name":"Dutch Arthritis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ard.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:58:08Z","timestamp":1779911888000},"page":"1486-1494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-6904","authenticated-orcid":false,"given":"Mitra Hosseini","family":"Malekroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6299-7653","authenticated-orcid":false,"given":"Stijn","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3251-0238","authenticated-orcid":false,"given":"Hanna W.","family":"van Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-790X","authenticated-orcid":false,"given":"Elise","family":"van Mulligen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-1437","authenticated-orcid":false,"given":"Annette H.M.","family":"van der Helm-van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ard.2026.04.011_bib0001","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5152\/eurjrheum.2017.16006","article-title":"Pre-rheumatoid arthritis and its prevention","volume":"4","author":"Paul","year":"2017","journal-title":"Eur J Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.04.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004714","article-title":"Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia?","volume":"10","author":"Claassen","year":"2024","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.ard.2026.04.011_bib0003","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.ard.2026.04.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005377","article-title":"Time sequence of autoimmune processes in the trajectory to rheumatoid arthritis development: what do we know?","volume":"11","author":"Heutz","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.ard.2026.04.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104233","article-title":"ACPA-negative rheumatoid arthritis: from immune mechanisms to clinical translation","volume":"83","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ard.2026.04.011_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003296","article-title":"Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands","volume":"17","author":"Matthijssen","year":"2020","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.ard.2026.04.011_bib0007","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"10.1016\/j.ard.2026.04.011_bib0008","article-title":"Forefoot inflammation in recent-onset ACPA-positive and ACPA-negative RA: clinically similar, but different in underlying inflamed tissues","volume":"10","author":"DA","year":"2024","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.ard.2026.04.011_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180655","article-title":"Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se","volume":"12","author":"Murphy","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ard.2026.04.011_bib0010","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/ar3813","article-title":"Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA)","volume":"14","author":"Too","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"6","key":"10.1016\/j.ard.2026.04.011_bib0011","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/rheumatology\/keaf083","article-title":"Shorter reproductive time span and early menopause increase the risk of ACPA-negative inflammatory arthritis in postmenopausal women with clinically suspect arthralgia","volume":"64","author":"Heutz","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"22","key":"10.1016\/j.ard.2026.04.011_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212386","article-title":"The genetic, environmental, and immunopathological complexity of autoantibody-negative rheumatoid arthritis","volume":"22","author":"De Stefano","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"10","key":"10.1016\/j.ard.2026.04.011_bib0013","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"10348","key":"10.1016\/j.ard.2026.04.011_bib0014","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ard.2026.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/annrheumdis-2014-205522","article-title":"Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI","volume":"74","author":"van Steenbergen","year":"2015","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"10.1016\/j.ard.2026.04.011_bib0016","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2012-202289","article-title":"Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics","volume":"72","author":"van Nies","year":"2013","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.04.011_bib0017","first-page":"1385","article-title":"OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system","volume":"30","author":"\u00d8stergaard","year":"2003","journal-title":"J Rheumatol."},{"issue":"12","key":"10.1016\/j.ard.2026.04.011_bib0018","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/rheumatology\/kew335","article-title":"Older age is associated with more MRI-detected inflammation in hand and foot joints","volume":"55","author":"Nieuwenhuis","year":"2016","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ard.2026.04.011_bib0019","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar4322","article-title":"ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression","volume":"15","author":"van Beers","year":"2013","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.ard.2026.04.011_bib0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.42098","article-title":"IgG anti\u2013citrullinated protein antibody variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter: a cross-sectional study encompassing \u223c 1,500 samples","volume":"74","author":"Kissel","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.04.011_bib0021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","article-title":"Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis","volume":"59","author":"de Brito Rocha","year":"2019","journal-title":"Adv Rheumatol."},{"key":"10.1016\/j.ard.2026.04.011_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis\u2013laboratory and clinical perspectives","volume":"12","author":"R\u00f6nnelid","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.ard.2026.04.011_bib0023","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1756-185X.13000","article-title":"Only rheumatoid factor-positive subset of anti-citrullinated peptide\/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide\/protein antibody-positive","volume":"20","author":"R","year":"2017","journal-title":"Int J Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.04.011_bib0024","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/ard-2023-224728","article-title":"In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation","volume":"83","author":"Pertsinidou","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.04.011_bib0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/annrheumdis-2011-200259","article-title":"Level of agreement of the 1987 ACR and 2010 ACR\/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data","volume":"71","author":"Fautrel","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.04.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103421","article-title":"Should ACR\/EULAR criteria be revised changing the RF and ACPA scores?","volume":"23","author":"Steiner","year":"2024","journal-title":"Autoimmun Rev."},{"issue":"2","key":"10.1016\/j.ard.2026.04.011_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000752","article-title":"Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR\/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial","volume":"4","author":"Nordberg","year":"2018","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.ard.2026.04.011_bib0028","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/annrheumdis-2020-218221","article-title":"Do autoantibody-responses mature between presentation with arthralgia suspicious for progression to rheumatoid arthritis and development of clinically apparent inflammatory arthritis? A longitudinal serological study","volume":"80","author":"Wouters","year":"2021","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.04.011_bib0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-018-1591-2","article-title":"Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example","volume":"20","author":"Boeters","year":"2018","journal-title":"Arthritis Res Ther."},{"issue":"10","key":"10.1016\/j.ard.2026.04.011_bib0030","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/annrheumdis-2017-211325","article-title":"Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis","volume":"76","author":"Burgers","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"9","key":"10.1016\/j.ard.2026.04.011_bib0031","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/art.43175","article-title":"Serum proteomic signatures before the diagnosis of rheumatoid arthritis: evolving biologic pathways and specific periods of disease development","volume":"77","author":"Rachid Zaim","year":"2025","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.ard.2026.04.011_bib0032","doi-asserted-by":"crossref","first-page":"140","DOI":"10.14744\/nci.2023.81231","article-title":"Impact of central sensitization on clinical parameters in patients with rheumatoid arthritis","volume":"11","author":"Mesci","year":"2024","journal-title":"North Clin Istanb."},{"issue":"9","key":"10.1016\/j.ard.2026.04.011_bib0033","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/rheumatology\/keae044","article-title":"Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?","volume":"63","author":"Khidir","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ard.2026.04.011_bib0034","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2665-9913(20)30061-8","article-title":"Referring early arthritis patients within 6 weeks versus 12 weeks after symptom onset: an observational cohort study","volume":"2","author":"Niemantsverdriet","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"12","key":"10.1016\/j.ard.2026.04.011_bib0035","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1016\/S2665-9913(24)00196-6","article-title":"Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial","volume":"6","author":"Dumoulin","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ard.2026.04.011_bib0036","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ard.2025.05.326","volume":"84","author":"Dumoulin","year":"2025","journal-title":"Ann Rheum Dis."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:58:56Z","timestamp":1793595536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0003496726002700"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.04.011","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}